Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide for Dry Mouth in Sjögren's Syndrome
NCT00233363Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Apr 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sjögren's syndrome comparing Rebamipide with Placebo (2 arms). Primary endpoint: Overall Improvement Rate in Dry Mouth Symptoms at 8 weeks. Started Apr 2005; status: completed.
02
Drugs
rebamipide
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT00233363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233363.